A detailed history of Cibc World Markets Corp transactions in Pfizer Inc stock. As of the latest transaction made, Cibc World Markets Corp holds 1,089,321 shares of PFE stock, worth $31.7 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,089,321
Previous 579,050 88.12%
Holding current value
$31.7 Million
Previous $16.1 Million 89.69%
% of portfolio
0.2%
Previous 0.11%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$25.26 - $29.6 $12.9 Million - $15.1 Million
510,271 Added 88.12%
1,089,321 $30.5 Million
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $17 Million - $19.5 Million
-657,282 Reduced 53.16%
579,050 $16.1 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $24.2 Million - $31.4 Million
924,710 Added 296.74%
1,236,332 $35.6 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $11.2 Million - $13.1 Million
-349,971 Reduced 52.9%
311,622 $10.3 Million
Q2 2023

Aug 04, 2023

BUY
$36.12 - $41.79 $6.89 Million - $7.97 Million
190,699 Added 40.5%
661,593 $24.3 Million
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $9.73 Million - $12.7 Million
-247,137 Reduced 34.42%
470,894 $19.2 Million
Q4 2022

Feb 09, 2023

BUY
$41.75 - $54.5 $26.4 Million - $34.5 Million
632,872 Added 743.17%
718,031 $36.8 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $13.4 Million - $16.4 Million
-306,538 Reduced 78.26%
85,159 $3.73 Million
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $58.8 Million - $69.7 Million
-1,263,002 Reduced 76.33%
391,697 $20.5 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $8.97 Million - $11.1 Million
196,148 Added 13.45%
1,654,699 $85.7 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $3.79 Million - $5.62 Million
91,750 Added 6.71%
1,458,551 $86.1 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $38.4 Million - $49.3 Million
978,142 Added 251.67%
1,366,801 $58.8 Million
Q2 2021

Aug 10, 2021

SELL
$35.91 - $40.68 $5.14 Million - $5.82 Million
-143,085 Reduced 26.91%
388,659 $15.2 Million
Q1 2021

May 07, 2021

SELL
$33.49 - $37.77 $31.2 Million - $35.2 Million
-930,719 Reduced 63.64%
531,744 $19.3 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $26.6 Million - $33.8 Million
793,258 Added 118.54%
1,462,463 $53.8 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $3.57 Million - $4.19 Million
112,570 Added 20.22%
669,205 $24.6 Million
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $926,430 - $1.12 Million
-30,758 Reduced 5.24%
556,635 $18.2 Million
Q1 2020

May 12, 2020

SELL
$27.03 - $38.62 $16.5 Million - $23.6 Million
-611,472 Reduced 51.0%
587,393 $19.2 Million
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $31.2 Million - $35.4 Million
-947,552 Reduced 44.15%
1,198,865 $47 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $24 Million - $31.1 Million
737,969 Added 52.4%
2,146,417 $77.1 Million
Q2 2019

Aug 13, 2019

SELL
$36.98 - $41.52 $1.67 Million - $1.88 Million
-45,233 Reduced 3.11%
1,408,448 $61 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $36.2 Million - $39.7 Million
-964,558 Reduced 39.89%
1,453,681 $61.7 Million
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $25.2 Million - $28.8 Million
655,712 Added 37.2%
2,418,239 $106 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $39.8 Million - $48.3 Million
-1,155,380 Reduced 39.6%
1,762,527 $77.7 Million
Q2 2018

Aug 13, 2018

BUY
$32.98 - $35.16 $6.03 Million - $6.43 Million
182,769 Added 6.68%
2,917,907 $106 Million
Q1 2018

May 11, 2018

SELL
$31.91 - $37.02 $82.4 Million - $95.6 Million
-2,582,892 Reduced 48.57%
2,735,138 $97.1 Million
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $4.45 Million - $4.72 Million
133,695 Added 2.58%
5,318,030 $193 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $161 Million - $177 Million
5,184,335
5,184,335 $185 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.